le jeudi 18 octobre 2018, à 15:59. Posté
par Antoine
Not in at the moment http://biznis-centar.edu.rs/stmap_690c0.html?altace.amiloride.protonix.viagra n1tv wiki CANbridge has already signed a deal with Texas-based Azaya Therapeutics to develop ATI-1123 for non-small cell lung cancer and potentially other solid tumours. The compound is a liposomal formulation of docetaxel and Phase II trials in the USA are planned in NSCLC, gastric cancer, pancreatic cancer and soft-tissue sarcoma.